Skip to content

Released Jul 24, 2019, after the close

10-Q filed Jul 31, 2019, 31 days after period end · 0001653477-19-000107

Q2 2019 · 10-Q
Revenue$352.80M+14.3% vs Q2 2018+27.5% vs Q1 2019
Net Income$56.80M+21.6% vs Q2 2018+150.2% vs Q1 2019
EPS Diluted$1.34+21.8% vs Q2 2018+148.1% vs Q1 2019
Gross Profit$134,400,000+16.4%
Operating Income$108,300,000+21.1%
Operating Cash Flowderived$79,500,000+29.5%
Free Cash Flowderived$49,900,000+12.6%
Margins · derived
Gross margin38.1%+0.7 pt vs Q2 2018
Operating margin30.7%+1.7 pt vs Q2 2018
Net margin16.1%+1.0 pt vs Q2 2018

What the release said

The release

Same quarter

MetricQ2 2019Q2 2018Q2 2017Q2 2016
Revenue$352.80M$308.60M$260.30M$245.40M
Net Income$56.80M$46.70M$32.10M$24.10M
EPS Diluted$1.34$1.10$0.76$0.57

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR